Interpace Biosciences®, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Note 9 - Accrued Expenses and Other Long-term Liabilities (Tables)

Note 9 - Accrued Expenses and Other Long-term Liabilities (Tables)

12 Months Ended

Dec. 31, 2016

Notes Tables

Schedule of Accrued Liabilities [Table Text Block]

		December 31, 2016				December 31, 2015
Accrued royalties		$	711			$	111
Insurance and benefit accruals			40				366
Indemnification liability			875				875
Contingent consideration			260				659
Rent payable			110				127
DOJ settlement			80				250
Accrued professional fees			1,746				775
Taxes payable			526				591
Unclaimed property			565				546
Directors fees and insurance			40				107
All others			1,283				1,554
Total other accrued expenses		$	6,236			$	5,961

Schedule of Other Assets and Other Liabilities [Table Text Block]

		December 31, 2016				December 31, 2015
Rent payable		$	-			$	52
Uncertain tax positions			3,594				3,425
DOJ settlement (indemnified by RedPath)			250				2,500
Other			-				201
Total other long-term liabilities		$	3,844			$	6,178